As the eye care unit of Novartis AG, CIBA Vision benefits from the strengths and resources of one of the largest healthcare companies in the world. Novartis is a world leader in healthcare, with core businesses in pharmaceuticals, consumer health, pediatrics, eye care and animal health.

A global leader in researching, manufacturing and development of contact lenses and contact lens care products, CIBA Vision was established in 1980 as a diversification effort of Ciba-Geigy's USA Pharmaceutical Division. In 1996 Ciba-Geigy and Sandoz merged, forming Novartis. Headquartered in Basel, Switzerland, Novartis companies employ approximately 80,000 people and operate in more than 140 countries around the world. CIBA Vision was formed to be the eye care unit for Novartis, providing contact lenses and lens care products to patients in over 70 countries around the world.

CIBA Vision offers a wide range of contact lenses to meet the needs of patients. They produce two week disposable lenses such as Choice AB, Focus 1-2 Week Visitint, NewVues and O2 Optix.

For patients needing bifocal lenses there are Focus Dailies Progressive, a daily disposable lens, and Focus Progressives, which are two week disposable lenses.

CIBA Vision also manufactures contact lenses for patients looking to alter the color of their eyes, and in 1984 was among the first to do so. They offer Focus Monthly SoftColors and Focus 1-2 Week SoftColors.

Patients looking for extended wear contact lenses can choose between Focus Monthly Visitint and Focus Night & Day lenses.